# Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis

> **NCT07556393** · PHASE2 · COMPLETED · sponsor: **Inimmune Corporation** · enrollment: 78 (actual)

## Conditions studied

- Allergic Rhinitis Due to Allergens
- Rhinitis Allergic
- Allergic Rhinitis

## Interventions

- **DRUG:** INI-2004
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07556393
- **Lead sponsor:** Inimmune Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-19
- **Primary completion:** 2026-04-23
- **Final completion:** 2026-04-23
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07556393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07556393, "Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07556393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*